Rhumbline Advisers Raises Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO)
Rhumbline Advisers lifted its stake in shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) by 19.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,197 shares of the company’s stock after purchasing an additional 4,127 shares during the period. […]
Rhumbline Advisers lifted its stake in shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) by 19.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,197 shares of the company’s stock after purchasing an additional 4,127 shares during the period. […]
